GLP-1 retseptori agonistide kliiniline tõenduspõhisus ja kulutõhusus 2. tüüpi diabeedi ravis: tervisetehnoloogia hindamise raport TTH33

dc.contributor.authorJuus, Eva
dc.contributor.authorVolke, Vallo
dc.contributor.authorRoosimaa, Mart
dc.contributor.authorLutsar, Katrin
dc.contributor.authorLukka, Mari
dc.contributor.authorKiivet, Raul-Allan
dc.contributor.otherTartu ülikool. Peremeditsiini ja rahvatervishoiu instituut
dc.date.accessioned2018-03-21T14:19:15Z
dc.date.accessioned2022-09-21T08:46:22Z
dc.date.available2018-03-21T14:19:15Z
dc.date.available2022-09-21T08:46:22Z
dc.date.issued2017
dc.descriptionReport in Estonian, summary in English
dc.identifier.urihttp://hdl.handle.net/10062/84152
dc.publisherTartu
dc.subjectdiabeet
dc.subjectravimid
dc.subjectkulutõhusus
dc.subjecttervisetehnoloogiate hindamine
dc.subjecthealth technology assessment
dc.titleGLP-1 retseptori agonistide kliiniline tõenduspõhisus ja kulutõhusus 2. tüüpi diabeedi ravis: tervisetehnoloogia hindamise raport TTH33
dc.title.alternativeThe clinical effectiveness and cost-effectiveness of GLP-1 receptor agonists for the treatment of type 2 diabetes mellitus in Estonia: health technology assessment report HTA33
dc.typeTTH_raport

Files

Original bundle

Now showing 1 - 2 of 2
Loading...
Thumbnail Image
Name:
TTH33_GLP_1.pdf
Size:
1.79 MB
Format:
Adobe Portable Document Format
Description:
Loading...
Thumbnail Image
Name:
TTH33_GLP_1_summary.pdf
Size:
142.23 KB
Format:
Adobe Portable Document Format
Description:

License bundle

Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
98 B
Format:
Plain Text
Description: